CHRNA7 and Alzheimer disease: Overall, α7nAChR expression and functioning offer neuroprotection against neurotoxic Aβ1–42 through autophagic degradation in vitro and in vivo, and using drugs to stimulate the function or expression of α7nAChR is a potential AD therapeutic strategy [32,46,48,52].